Series D brings in an initial $25mm for Intact Vascular
Executive Summary
Intact Vascular Inc. (minimally invasive devices for peripheral vascular procedures) raised $25mm through its Series D financing led by Vensana Capital, which was joined by returning shareholders New Enterprise Associates, HIG BioHealth Partners, and Quaker Partners. The company expects another tranche in 2020. Intact Vascular will use the funds to expand sales and marketing activities, and clinical support staffing for its Tack endovascular system for dissection repair following above-the-knee balloon angioplasty. Concurrently, Vesper Medical Inc., which spun out from Intact Vascular in 2016 and is also developing devices for minimally invasive peripheral vascular procedures, raised $37mm in a financing from Vensana Capital, Gilde Healthcare, NEA, and Quaker Partners.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice